These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18187211)

  • 21. Linking variability in brain chemistry and circuit function through multimodal human neuroimaging.
    Fisher PM; Hariri AR
    Genes Brain Behav; 2012 Aug; 11(6):633-42. PubMed ID: 22443230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation.
    Salavati B; Rajji TK; Price R; Sun Y; Graff-Guerrero A; Daskalakis ZJ
    Schizophr Bull; 2015 Jan; 41(1):44-56. PubMed ID: 25249654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.
    Chou PH; Koike S; Nishimura Y; Kawasaki S; Satomura Y; Kinoshita A; Takizawa R; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():63-9. PubMed ID: 24275075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional brain imaging of symptoms and cognition in schizophrenia.
    Kircher TT; Thienel R
    Prog Brain Res; 2005; 150():299-308. PubMed ID: 16186032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of PET technique for the development and evaluation of novel antipsychotics.
    Takano A
    Curr Pharm Des; 2010 Jan; 16(3):371-7. PubMed ID: 20109145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.
    Busatto GF
    Schizophr Bull; 2013 Jul; 39(4):776-86. PubMed ID: 23615813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroimaging of epilepsies].
    Vollmar C; la Fougère C
    Nervenarzt; 2012 Feb; 83(2):167-71. PubMed ID: 22349768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies.
    van Kuyck K; Gérard N; Van Laere K; Casteels C; Pieters G; Gabriëls L; Nuttin B
    J Psychiatr Res; 2009 Sep; 43(14):1133-45. PubMed ID: 19442986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neural areas of emotions in normal and brain pathology assessed by functional neuroimaging methods].
    Kucharska-Pietura K; Pietura R; Masiak M
    Przegl Lek; 2002; 59(10):832-5. PubMed ID: 12632923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing targets for antipsychotic drug action with PET and SPET receptor imaging.
    Pilowsky LS
    Nucl Med Commun; 2001 Jul; 22(7):829-33. PubMed ID: 11453058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia.
    Ergün EL; Volkan-Salanci B; Ertugrul A; Demir B; Erbas B
    Hell J Nucl Med; 2010; 13(1):35-9. PubMed ID: 20411169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET and SPET molecular imaging: focus on serotonin system.
    Moresco RM; Matarrese M; Fazio F
    Curr Top Med Chem; 2006; 6(18):2027-34. PubMed ID: 17017972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular imaging PET and SPECT approaches for improving productivity of antipsychotic drug discovery and development.
    Catafau AM; Bullich S
    Curr Med Chem; 2013; 20(3):378-88. PubMed ID: 23157630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimaging procedures and related acquisitions in bipolar disorder: state of the art.
    Dell'Osso B; Dobrea C; Palazzo MC; Cremaschi L; Penzo B; Benatti B; Camuri G; Arici C; Suppes T; Altamura AC
    Riv Psichiatr; 2014; 49(1):2-11. PubMed ID: 24572578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
    Cumming P; Abi-Dargham A; Gründer G
    Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Techniques for brain imaging in vivo.
    Garcia-Alloza M; Bacskai BJ
    Neuromolecular Med; 2004; 6(1):65-78. PubMed ID: 15781977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcranial magnetic stimulation in schizophrenia: the contribution of neuroimaging.
    Du ZD; Wang R; Prakash R; Chaudhury S; Dayananda G
    Curr Top Med Chem; 2012; 12(21):2452-7. PubMed ID: 23409741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.
    Kasper S; Tauscher J; Küfferle B; Barnas C; Pezawas L; Quiner S
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():83-9. PubMed ID: 10654113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
    Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
    Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroanatomy and neurophysiology in schizophrenia.
    Kasai K; Iwanami A; Yamasue H; Kuroki N; Nakagome K; Fukuda M
    Neurosci Res; 2002 Jun; 43(2):93-110. PubMed ID: 12067745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.